Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Substance Abuse, Substance Use Disorder (SUD)_Opioid, Alcohol, Tobacco, Etc.
Recro Pharma (NASDAQ:REPH)

Organization & Developments: Recro

Parents

2017: The company reported successful results in a Phase 3 safety study for IV meloxicam.
2018: Recro Pharma Tumbles On FDA CRL, Now In Oversold Territory - Recro Pharma Inc (NASDAQ:REPH)
2020: Baudax Bio: Discounted Despite Long-Term Prospects
2021: Revisiting Recro Pharma
Baudax Bio, Inc. (NASDAQ: BXRX)
Recro Pharma inhabits a specialty niche in the pharmaceutical world, as a contract development and manufacturing organization (CDMO).
The company offers top-of-the-line manufacturing facilities to larger pharmaceutical researchers, allowing those firms to concentrate on finding and testing new drugs – while Recro handles serial manufacturing for approved medications.